Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学T-Cell Lymphoma, PTCL-NOS

James O'Day

MBBS, FRACP, FRCPA

🏢Epworth Hospital / Peter MacCallum Cancer Centre🌐Australia

Clinical Haematologist

26
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

James O'Day is an Australian hematologist with clinical expertise in peripheral T-cell lymphoma, particularly PTCL-NOS, who has contributed to cooperative group studies and outcomes research in this difficult-to-treat entity. He participates in the Australasian Leukaemia and Lymphoma Group (ALLG) and has co-authored important analyses of long-term outcomes following various frontline and salvage regimens for PTCL.

Share:

🧪Research Fields 研究领域

PTCL-NOS clinical outcomes
T-cell lymphoma Australia
frontline PTCL
CHOEP regimen PTCL
PTCL salvage treatment

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 James O'Day 的研究动态

Follow James O'Day's research updates

留下邮箱,当我们发布与 James O'Day(Epworth Hospital / Peter MacCallum Cancer Centre)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment